Sandoz v Bayer [2024] EWHC 796 (Pat)

Bayer owns European Patent (UK) No. 1 845 961 (the “Patent”), which concerns once daily dosing of rivaroxaban (a blockbuster blood-thinning drug). The Claimants (generics pharmaceutical companies: Sandoz, Teva, Accord, CIPLA, Amarox, Viatris and STADA) sought revocation of the Patent on the grounds of obviousness over a poster entitled “Effects of Bay 59-7939, an Oral, Direct FXa Inhibitor, on Thrombin Generation in Healthy Volunteers”, by Sebastian Harder et al (“Harder”), which was made available to the public at the 45th Annual Meeting of the American Society of Hematology in San Diego, USA, held between 6-9 December 2003 together with various abstracts cited in the Blood journal in 2003.

Hacon HJJ heard the trial between 9 and 22 February 2024. The Judge decided that the Patent is invalid as the Claimants alleged.

Adam Gamsa appeared as junior counsel for the Claimants: Sandoz, Teva, Accord, CIPLA, Amarox, Viatris and STADA, instructed by Pinsent Masons, Bristows, Penningtons Manches Cooper, HGF Law and Taylor Wessing.

[2024] EWHC 796 (Pat)

Latest News

Anna Edwards-Stuart appointed King’s Counsel

Chambers is delighted to announce that Anna Edwards-Stuart has been appointed King’s Counsel in the 2023 competition, announced on 19th January 2024.

Miruna Bercariu joins 11 South Square

Chambers is delighted to announce Miruna Bercariu has accepted an offer of tenancy after a successful pupillage and will commence practice immediately....

Chambers UK Bar Awards 2023

Chambers is thrilled to announce we have won all three of the awards we were nominated for at the Chambers UK Bar Awards 2023. 11 South Square, IT/IP Set of the Year Brian Nicholson KC, IT/IP Silk of the Year Ka...

Edward Cronan joins 11 South Square

We are pleased to announce the arrival of a new member of chambers, Edward Cronan. Edward first came on to our radar at 11 South Square when he was a solicitor, and we watched his move to the bar in 2018 with interest. S...

Bio-science Law Review – University Inventions: When is a student a consumer?

University Inventions: When is a student a consumer? Oxford University Innovation Limited v Oxford Nanoimaging Limited [2022] EWHC 3200 (Pat) This article provides a case comment on the Judgment of Daniel Alexander KC...

Michael Silverleaf called to the Irish Bar

Chambers is pleased to announce that Michael Silverleaf has been called to the Irish Bar and has appeared in that role as part of a team representing Bristol-Myers Squibb in the Irish High Court before Barrett J. The tri...

Lionel Bently made Honorary King’s Counsel

Chambers is delighted to announce that Lionel Bently has been made an Honorary King's Counsel. Honorary KCs are awarded to those who have made a major contribution to the law of England and Wales, outside practice in...